Demirtas, C.O.; Eren, F.; Yilmaz Karadag, D.; Kaldirim Armutcuoglu, Y.; Tolu, T.; Huseyinov, J.; Ciftci, U.; Yilmaz, T.; Akin, S.; Dilber, F.;
et al. BALAD-2 Emerges as the Most Accurate Prognostic Model in Hepatocellular Carcinoma: Results from a Biobank-Based Cohort Study. Cancers 2025, 17, 3457.
https://doi.org/10.3390/cancers17213457
AMA Style
Demirtas CO, Eren F, Yilmaz Karadag D, Kaldirim Armutcuoglu Y, Tolu T, Huseyinov J, Ciftci U, Yilmaz T, Akin S, Dilber F,
et al. BALAD-2 Emerges as the Most Accurate Prognostic Model in Hepatocellular Carcinoma: Results from a Biobank-Based Cohort Study. Cancers. 2025; 17(21):3457.
https://doi.org/10.3390/cancers17213457
Chicago/Turabian Style
Demirtas, Coskun Ozer, Fatih Eren, Demet Yilmaz Karadag, Yasemin Kaldirim Armutcuoglu, Tugba Tolu, Javid Huseyinov, Ugur Ciftci, Tuba Yilmaz, Sehnaz Akin, Feyza Dilber,
and et al. 2025. "BALAD-2 Emerges as the Most Accurate Prognostic Model in Hepatocellular Carcinoma: Results from a Biobank-Based Cohort Study" Cancers 17, no. 21: 3457.
https://doi.org/10.3390/cancers17213457
APA Style
Demirtas, C. O., Eren, F., Yilmaz Karadag, D., Kaldirim Armutcuoglu, Y., Tolu, T., Huseyinov, J., Ciftci, U., Yilmaz, T., Akin, S., Dilber, F., & Ozdogan, O. C.
(2025). BALAD-2 Emerges as the Most Accurate Prognostic Model in Hepatocellular Carcinoma: Results from a Biobank-Based Cohort Study. Cancers, 17(21), 3457.
https://doi.org/10.3390/cancers17213457